GT Biopharma, Inc. — Investor Relations & Filings
Filings indexed
854
across all filing types
Latest filing
2026-04-07
Regulatory Filings
Country
US
United States of America
Listing
US
GTBP
GT Biopharma, Inc. is a clinical-stage immuno-oncology company focused on developing innovative therapies based on its proprietary NK cell engager (TriKE®) technology. The TriKE® platform generates therapeutic agents that are designed to simultaneously bind to Natural Killer (NK) cells and cancer cells. This targeted engagement activates and directs the cytotoxic function of NK cells to selectively destroy malignant cells. The company's pipeline targets a range of hematologic malignancies and solid tumors, including acute myeloid leukemia, myeloid dysplastic syndrome, and non-Hodgkin's lymphoma.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - GT Biopharma, Inc. (0000109657) (Filer) | 2026-04-07 | English | |
| 10-K - GT BIOPHARMA, INC. (0000109657) (Filer) | 2026-03-02 | English | |
| 8-K - GT BIOPHARMA, INC. (0000109657) (Filer) | 2026-03-02 | English | |
| 424B3 Filing | 2026-01-30 | English | |
| S-1 Filing | 2026-01-21 | English | |
| 424B3 Filing | 2026-01-08 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 33703557 | 8-K - GT Biopharma, Inc. (0000109657) (Filer) | 2026-04-07 | English | ||
| 32879155 | 10-K - GT BIOPHARMA, INC. (0000109657) (Filer) | 2026-03-02 | English | ||
| 32879154 | 8-K - GT BIOPHARMA, INC. (0000109657) (Filer) | 2026-03-02 | English | ||
| 17484916 | 424B3 Filing | 2026-01-30 | English | ||
| 17484931 | S-1 Filing | 2026-01-21 | English | ||
| 17484908 | 424B3 Filing | 2026-01-08 | English | ||
|
2025
9 filings
| |||||
| 9203930 | Regulatory Filings 2025 | 2025-12-03 | English | ||
| 9203929 | 424B3 | 2025-12-02 | English | ||
| 8987014 | 8-K | 2025-11-26 | English | ||
| 8987024 | 10-Q | 2025-11-14 | English | ||
| 8987028 | 8-K | 2025-11-14 | English | ||
| 8987032 | S-1 | 2025-10-24 | English | ||
| 8987035 | 8-K | 2025-09-26 | English | ||
| 8987037 | 8-K | 2025-09-23 | English | ||
| 8987039 | Director's Dealing 2025 | 2025-09-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
GT Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35496/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35496 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35496 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35496 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35496}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GT Biopharma, Inc. (id: 35496)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.